Pulmonary Tuberculosis — Rehabilitation of People With Post-tuberculosis Lung Disease
Citation(s)
Aggarwal AN, Gupta D, Janmeja AK, Jindal SK Assessment of health-related quality of life in patients with pulmonary tuberculosis under programme conditions. Int J Tuberc Lung Dis. 2013 Jul;17(7):947-53. doi: 10.5588/ijtld.12.0299.
Brasil Ministério da Saúde. Manual de Recomendações para o Controle da Tuberculose no Brasil 2019. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/manual_recomendacoes_controle_tuberculose_brasil_2_ed.pdf
Caglar Tosun BN, Zeren M, Barlik M, Demir E, Gulen F Investigation of dynamic hyperinflation and its relationship with exercise capacity in children with bronchiectasis. Pediatr Pulmonol. 2022 Sep;57(9):2218-2226. doi: 10.1002/ppul.26028. Epub 2022 Jun 14.
Daniels KJ, Irusen E, Pharaoh H, Hanekom S Post-tuberculosis health-related quality of life, lung function and exercise capacity in a cured pulmonary tuberculosis population in the Breede Valley District, South Africa. S Afr J Physiother. 2019 Jul 31;75(1):1319. doi: 10.4102/sajp.v75i1.1319. eCollection 2019.
De Sousa TC, Jardim JR, Jones P Validation of the Saint George's Respiratory Questionnaire in patients with chronic obstructive pulmonary disease in Brazil. J Pneumologia 2000; 26(3): 119-128.
Dias VL, Canan MGM, Leitao CA, Okuno EA, de Sant'Ana GRD, Miranda JV Profile of patients with post-tuberculosis bronchiectasis in a tertiary care hospital in Brazil. J Clin Tuberc Other Mycobact Dis. 2022 Nov 13;29:100339. doi: 10.1016/j.jctube.2022.100339. eCollection 2022 Dec.
Hill K, Jenkins SC, Cecins N, Philippe DL, Hillman DR, Eastwood PR Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2008 Sep;89(9):1782-7. doi: 10.1016/j.apmr.2008.01.020.
Hnizdo E, Singh T, Churchyard G Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000 Jan;55(1):32-8. doi: 10.1136/thorax.55.1.32.
Hulya S, Naz I, Karadeniz G, Erkan S Clinical effects of TB sequelae in patients with COPD. Int J Tuberc Lung Dis. 2022 Apr 1;26(4):363-368. doi: 10.5588/ijtld.21.0419.
Ivanova O, Hoffmann VS, Lange C, Hoelscher M, Rachow A Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people. Eur Respir Rev. 2023 Apr 19;32(168):220221. doi: 10.1183/16000617.0221-2022. Print 2023 Jun 30.
Kosko B Fuzzy Engineering. New Jersey: Prentice-Hall; 1997
Lima TRL, Kasuki L, Gadelha M, Lopes AJ Physical exercise improves functional capacity and quality of life in patients with acromegaly: a 12-week follow-up study. Endocrine. 2019 Nov;66(2):301-309. doi: 10.1007/s12020-019-02011-x. Epub 2019 Jul 17.
Miyamoto ST Exercício aeróbico na síndrome de Sjogren primária: estudo controlado e randomizado. Tese de Doutorado. Universidade Federal de São Paulo. São Paulo: UNIFESP, 2016.
Monteiro F, Ponce DA, Silva H, Carrilho AF, Pitta F Validity and Reproducibility of the Glittre ADL-Test in Obese and Post-Bariatric Surgery Patients. Obes Surg. 2017 Jan;27(1):110-114. doi: 10.1007/s11695-016-2244-7.
Neder JA, Andreoni S, Castelo-Filho A, Nery LE Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res. 1999 Jun;32(6):703-17. doi: 10.1590/s0100-879x1999000600006.
Neder JA, Andreoni S, Lerario MC, Nery LE Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999 Jun;32(6):719-27. doi: 10.1590/s0100-879x1999000600007.
Neder JA, Andreoni S, Peres C, Nery LE Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res. 1999 Jun;32(6):729-37. doi: 10.1590/s0100-879x1999000600008.
Nonato CP, Azevedo BLPA, Oliveira JGM, Gardel DG, de Souza DCN, Lopes AJ The Glittre Activities of Daily Living Test in women with scleroderma and its relation to hand function and physical capacity. Clin Biomech (Bristol, Avon). 2020 Mar;73:71-77. doi: 10.1016/j.clinbiomech.2020.01.008. Epub 2020 Jan 11.
Pereira CA, Sato T, Rodrigues SC New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007 Jul-Aug;33(4):397-406. doi: 10.1590/s1806-37132007000400008. English, Portuguese.
Pereira CAC, Moreira MAF Pletismografia: resistência das vias aéreas. J Bras Pneumol. 2002; 28(3): 139-150.
Pereira CAC Espirometria. J Bras Pneumol. 2002; 28(Supl. 3): 1-82.
Ravimohan S, Kornfeld H, Weissman D, Bisson GP Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018 Feb 28;27(147):170077. doi: 10.1183/16000617.0077-2017. Print 2018 Mar 31.
Reis CMD, Karloh M, Fonseca FR, Biscaro RRM, Mazo GZ, Mayer AF Functional capacity measurement: reference equations for the Glittre Activities of Daily Living test. J Bras Pneumol. 2018 Sep-Oct;44(5):370-377. doi: 10.1590/S1806-37562017000000118. Epub 2018 Jul 16.
Ross TJ Fuzzy Logic with Engineering Applications. New York: McGraw-Hill; 1995.
Ryu YJ, Lee JH, Chun EM, Chang JH, Shim SS Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis. 2011 Feb;15(2):246-50, i.
Secretaria de Vigilância em Saúde Ministério da Saúde Boletim Epidemiológico de Tuberculose. Número Especial -. Março 2022. Brasília: 2022. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2022/.
Silva DR, Gazzana MB, Barreto SS, Knorst MM Idiopathic pulmonary fibrosis and emphysema in smokers. J Bras Pneumol. 2008 Oct;34(10):779-86. doi: 10.1590/s1806-37132008001000005. English, Portuguese.
Skumlien S, Hagelund T, Bjortuft O, Ryg MS A field test of functional status as performance of activities of daily living in COPD patients. Respir Med. 2006 Feb;100(2):316-23. doi: 10.1016/j.rmed.2005.04.022. Epub 2005 Jun 6.
Visca D, Centis R, Munoz-Torrico M, Pontali E Post-tuberculosis sequelae: the need to look beyond treatment outcome. Int J Tuberc Lung Dis. 2020 Aug 1;24(8):761-762. doi: 10.5588/ijtld.20.0488. No abstract available.
Wang J, Xiong K, Zhao S, Zhang C, Zhang J, Xu L, Ma A Long-Term Effects of Multi-Drug-Resistant Tuberculosis Treatment on Gut Microbiota and Its Health Consequences. Front Microbiol. 2020 Jan 30;11:53. doi: 10.3389/fmicb.2020.00053. eCollection 2020.
World Health Organization Global tuberculosis report 2021]. Geneva: WHO; 2021. Global Tuberculosis Report 2021. Disponível em: https://www.who.int/publications/i/item/9789240037021.
World Health Organization Global Tuberculosis Report 2022. Geneva: WHO; c2022. Disponível em: https://www.who.int/teams/global-tuberculosis-programme/tbreports/global-tuberculosis-report-2022.
Rehabilitation of People With Post-tuberculosis Lung Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.